74777
黄芪甲苷IV
>98.0%
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C41H68O14
化学文摘社编号:
分子量:
784.97
NACRES:
NA.85
PubChem Substance ID:
UNSPSC Code:
41106200
MDL number:
产品名称
黄芪甲苷IV, >98.0%
InChI
1S/C41H68O14/c1-35(2)24(54-33-29(48)26(45)20(44)17-51-33)9-11-41-18-40(41)13-12-37(5)31(39(7)10-8-25(55-39)36(3,4)50)19(43)15-38(37,6)23(40)14-21(32(35)41)52-34-30(49)28(47)27(46)22(16-42)53-34/h19-34,42-50H,8-18H2,1-7H3/t19-,20+,21-,22+,23-,24-,25-,26-,27+,28-,29+,30+,31-,32-,33-,34+,37+,38-,39+,40-,41+/m0/s1
SMILES string
CC(C)(O)[C@@H]1CC[C@@](C)(O1)[C@H]2[C@@H](O)C[C@@]3(C)[C@@H]4C[C@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@H]6C(C)(C)[C@H](CC[C@@]67C[C@@]47CC[C@]23C)O[C@@H]8OC[C@@H](O)[C@H](O)[C@H]8O
InChI key
QMNWISYXSJWHRY-YLNUDOOFSA-N
assay
≥98.0% (TLC)
>98.0%
form
powder
mp
295-296 °C (lit.)
Quality Level
正在寻找类似产品? 访问 产品对比指南
Biochem/physiol Actions
抗炎。
Other Notes
黄芪的化学成分
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
法规信息
新产品
此项目有
Dexin Li et al.
Pharmaceutical biology, 58(1), 89-97 (2020-01-08)
Context: Osteoarthritis (OA) is a degenerative arthrosis sickness. Astragaloside IV (AS-IV) functions by relieving inflammatory damage.Objective: We aimed to investigate the mechanism by which AS-IV protects ATD cells from lipopolysaccharide (LPS)-induced damage.Materials and methods: ATDC5 cells were transfected with miR-203
Chemical & Pharmaceutical Bulletin, 31, 709-709 (1983)
Xiaoyan Gu et al.
Molecular medicine reports, 6(1), 115-120 (2012-04-17)
Astragaloside IV (AS-IV) has been noted for its reduction of eosinophilic airway inflammation in a murine model of chronic asthma. To gain a better understanding of the mechanisms involved in this anti-inflammatory phenomenon, the effect of AS-IV on human blood
Rui-Na Zhou et al.
Drug metabolism and pharmacokinetics, 27(6), 586-597 (2012-06-08)
Astragaloside IV (AIV) is the most abundant saponin and a marker compound in Astragali Radix, a Chinese herb notable for its anti-aging and immune-enhancing effects. The present study investigated the role of intestinal bacterial conversion in the in vivo fate
Li-Hua Peng et al.
Biological & pharmaceutical bulletin, 35(6), 881-888 (2012-06-13)
Topical delivery of therapeutic agents at the time of injury to accelerate skin repair and prevent the formation of scars during the wound healing process has received increasing attention and represents a novel regenerative and prophylactic strategy for wound treatment.
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持